Stock Comparison

IONS vs REGN

Ionis Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

IONS

Ionis Pharmaceuticals Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$13.42B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

90.9

14.1

Price/Sales

12.7

4.5

Price/Book

27.3

2.1

EV/EBITDA

135.8

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-30.90%

29.60%

Operating Margin

-47.70%

20.70%

Return on Equity

-67.60%

14.50%

Return on Assets

-7.03%

6.13%

Growth (YoY)

Revenue Growth

87.00%

19.00%

Earnings Growth

-43.70%

-7.20%

Price & Risk

Beta

0.4

0.2

52-Week High

$86.74

$818.90

52-Week Low

$39.37

$516.07

Analyst Target

$105.91

$833.31

Compare IONS and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.